Groesbeck Parham to Uterine Cervical Neoplasms
This is a "connection" page, showing publications Groesbeck Parham has written about Uterine Cervical Neoplasms.
Connection Strength
9.945
-
Barrett C, Joseph JT, Horning MP, Anne M, Banik D, Birhanu F, Burkot S, Chisele S, Chizyuka N, Diallo M, Diop-Ndiaye H, Gaju S, Hu L, Jenison R, Kulhare S, Kuyper S, Laverriere Z, Makwakwa C, Malyangu E, Maparo T, Mukotsanjera C, Shah I, Shibemba AL, Tchereni T, Hariharan K, Parham G. Performance of an artificial intelligence-based tool for cervical precancer screening in five countries in Africa: a prospective, observational, diagnostic accuracy study. Lancet Glob Health. 2026 Jan; 14(1):e49-e60.
Score: 0.673
-
Basu P, Mwanahamuntu M, Pinder LF, Muwonge R, Lucas E, Nyambe N, Chisele S, Shibemba AL, Sauvaget C, Sankaranarayanan R, Prendiville W, Parham GP. A portable thermal ablation device for cervical cancer prevention in a screen-and-treat setting: a randomized, noninferiority trial. Nat Med. 2024 Sep; 30(9):2596-2604.
Score: 0.606
-
Hu L, Mwanahamuntu MH, Sahasrabuddhe VV, Barrett C, Horning MP, Shah I, Laverriere Z, Banik D, Ji Y, Shibemba AL, Chisele S, Munalula MK, Kaunga F, Musonda F, Malyangu E, Hariharan KM, Parham GP. Internal validation of Automated Visual Evaluation (AVE) on smartphone images for cervical cancer screening in a prospective study in Zambia. Cancer Med. 2024 Jun; 13(11):e7355.
Score: 0.603
-
Mwanahamuntu M, Kapambwe S, Pinder LF, Matambo J, Chirwa S, Chisele S, Basu P, Prendiville W, Sankaranarayanan R, Parham GP. The use of thermal ablation in diverse cervical cancer "screen-and-treat" service platforms in Zambia. Int J Gynaecol Obstet. 2022 Apr; 157(1):85-89.
Score: 0.495
-
Kapambwe S, Mwanahamuntu M, Pinder LF, Chisele S, Chirwa SC, Parham GP. Partnering with traditional Chiefs to expand access to cervical cancer prevention services in rural Zambia. Int J Gynaecol Obstet. 2019 Mar; 144(3):297-301.
Score: 0.415
-
Pinder LF, Henry-Tillman R, Linyama D, Kusweje V, Nzayisenga JB, Shibemba A, Sahasrabuddhe V, Lishimpi K, Mwanahamuntu M, Hicks M, Parham GP. Leverage of an Existing Cervical Cancer Prevention Service Platform to Initiate Breast Cancer Control Services in Zambia: Experiences and Early Outcomes. J Glob Oncol. 2018 09; 4:1-8.
Score: 0.378
-
Chibwesha CJ, Frett B, Katundu K, Bateman AC, Shibemba A, Kapambwe S, Mwanahamuntu MH, Banda S, Hamusimbi C, Polepole P, Parham GP. Clinical Performance Validation of 4 Point-of-Care Cervical Cancer Screening Tests in HIV-Infected Women in Zambia. J Low Genit Tract Dis. 2016 Jul; 20(3):218-23.
Score: 0.348
-
Kapambwe S, Sahasrabuddhe VV, Blevins M, Mwanahamuntu MH, Mudenda V, Shepherd BE, Chibwesha CJ, Pfaendler KS, Hicks ML, Vermund SH, Stringer JS, Parham GP. Implementation and Operational Research: Age Distribution and Determinants of Invasive Cervical Cancer in a "Screen-and-Treat" Program Integrated With HIV/AIDS Care in Zambia. J Acquir Immune Defic Syndr. 2015 Sep 01; 70(1):e20-6.
Score: 0.329
-
Parham GP, Mwanahamuntu MH, Kapambwe S, Muwonge R, Bateman AC, Blevins M, Chibwesha CJ, Pfaendler KS, Mudenda V, Shibemba AL, Chisele S, Mkumba G, Vwalika B, Hicks ML, Vermund SH, Chi BH, Stringer JS, Sankaranarayanan R, Sahasrabuddhe VV. Population-level scale-up of cervical cancer prevention services in a low-resource setting: development, implementation, and evaluation of the cervical cancer prevention program in Zambia. PLoS One. 2015; 10(4):e0122169.
Score: 0.320
-
Bateman AC, Chibwesha CJ, Parham GP. Minimizing verification bias in cervical cancer screening of HIV-infected women. Int J Gynaecol Obstet. 2015 Mar; 128(3):269-70.
Score: 0.310
-
Mwanahamuntu MH, Sahasrabuddhe VV, Blevins M, Kapambwe S, Shepherd BE, Chibwesha C, Pfaendler KS, Mkumba G, Vwalika B, Hicks ML, Vermund SH, Stringer JSA, Parham GP. Monitoring the performance of "screen-and-treat" cervical cancer prevention programs. Int J Gynaecol Obstet. 2014 Jul; 126(1):88-89.
Score: 0.296
-
De Vuyst H, Alemany L, Lacey C, Chibwesha CJ, Sahasrabuddhe V, Banura C, Denny L, Parham GP. The burden of human papillomavirus infections and related diseases in sub-saharan Africa. Vaccine. 2013 Dec 29; 31 Suppl 5:F32-46.
Score: 0.293
-
Mwanahamuntu MH, Sahasrabuddhe VV, Blevins M, Kapambwe S, Shepherd BE, Chibwesha C, Pfaendler KS, Mkumba G, Vwalika B, Hicks ML, Vermund SH, Stringer JS, Parham GP. Utilization of cervical cancer screening services and trends in screening positivity rates in a 'screen-and-treat' program integrated with HIV/AIDS care in Zambia. PLoS One. 2013; 8(9):e74607.
Score: 0.287
-
Mwanahamuntu MH, Sahasrabuddhe VV, Kapambwe S, Pfaendler KS, Chibwesha C, Mkumba G, Mudenda V, Hicks ML, Vermund SH, Stringer JS, Parham GP. Advancing cervical cancer prevention initiatives in resource-constrained settings: insights from the Cervical Cancer Prevention Program in Zambia. PLoS Med. 2011 May; 8(5):e1001032.
Score: 0.244
-
Parham GP, Mwanahamuntu MH, Pfaendler KS, Sahasrabuddhe VV, Myung D, Mkumba G, Kapambwe S, Mwanza B, Chibwesha C, Hicks ML, Stringer JS. eC3--a modern telecommunications matrix for cervical cancer prevention in Zambia. J Low Genit Tract Dis. 2010 Jul; 14(3):167-73.
Score: 0.230
-
Chirwa S, Mwanahamuntu M, Kapambwe S, Mkumba G, Stringer J, Sahasrabuddhe V, Pfaendler K, Parham G. Myths and misconceptions about cervical cancer among Zambian women: rapid assessment by peer educators. Glob Health Promot. 2010 Jun; 17(2 Suppl):47-50.
Score: 0.228
-
Mwanahamuntu MH, Sahasrabuddhe VV, Parham GP. HPV screening for cervical cancer in rural India. N Engl J Med. 2009 Jul 16; 361(3):305; author reply 306.
Score: 0.215
-
Mwanahamuntu MH, Sahasrabuddhe VV, Pfaendler KS, Mudenda V, Hicks ML, Vermund SH, Stringer JS, Parham GP. Implementation of 'see-and-treat' cervical cancer prevention services linked to HIV care in Zambia. AIDS. 2009 Mar 27; 23(6):N1-5.
Score: 0.211
-
Mwanahamuntu MH, Sahasrabuddhe VV, Stringer JS, Parham GP. Integrating cervical cancer prevention in HIV/AIDS treatment and care programmes. Bull World Health Organ. 2008 Aug; 86(8):D-E.
Score: 0.201
-
Pfaendler KS, Mwanahamuntu MH, Sahasrabuddhe VV, Mudenda V, Stringer JS, Parham GP. Management of cryotherapy-ineligible women in a "screen-and-treat" cervical cancer prevention program targeting HIV-infected women in Zambia: lessons from the field. Gynecol Oncol. 2008 Sep; 110(3):402-7.
Score: 0.199
-
Downs LS, Smith JS, Scarinci I, Flowers L, Parham G. The disparity of cervical cancer in diverse populations. Gynecol Oncol. 2008 May; 109(2 Suppl):S22-30.
Score: 0.198
-
Parham GP, Sahasrabuddhe VV, Mwanahamuntu MH, Shepherd BE, Hicks ML, Stringer EM, Vermund SH. Prevalence and predictors of squamous intraepithelial lesions of the cervix in HIV-infected women in Lusaka, Zambia. Gynecol Oncol. 2006 Dec; 103(3):1017-22.
Score: 0.175
-
Wynn TA, Johnson RE, Fouad M, Holt C, Scarinci I, Nagy C, Partridge E, Dignan MB, Person S, Parham G. Addressing disparities through coalition building: Alabama REACH 2010 lessons learned. J Health Care Poor Underserved. 2006 May; 17(2 Suppl):55-77.
Score: 0.172
-
Hicks ML, Yap OW, Matthews R, Parham G. Disparities in cervical cancer screening, treatment and outcomes. Ethn Dis. 2006; 16(2 Suppl 3):S3-63-6.
Score: 0.168
-
Leath CA, Straughn JM, Kirby TO, Huggins A, Partridge EE, Parham GP. Predictors of outcomes for women with cervical carcinoma. Gynecol Oncol. 2005 Nov; 99(2):432-6.
Score: 0.164
-
Fuady A, Kasempa C, Lucas E, Nyambe N, Rao DW, Tenet V, Broutet N, Muwonge R, Mwanahamuntu M, Baussano I, Parham GP, Basu P. Economic evaluation of thermal ablation compared to cryotherapy and loop diathermy in a screen-and-treat approach to cervical cancer, Zambia. Bull World Health Organ. 2025 Sep 01; 103(9):530-540.
Score: 0.163
-
Hill SK, Bempong-Ahun N, Okolo ID, Lalla AT, Worku D, Asres T, Philpotts L, Fallah PN, Varallo J, Corlew S, Kamfwa P, Parham GP, Hicks ML, Ibbotson G, Randall T. Improving access to safe, quality surgical care for gynecologic cancers through capacity-building interventions in low- and middle-income countries: A scoping review. Int J Gynaecol Obstet. 2024 May; 165(2):552-561.
Score: 0.145
-
Parham GP. Comparison of cell collection and direct visualization cervical cancer screening adjuncts. Am J Obstet Gynecol. 2003 Mar; 188(3 Suppl):S13-20.
Score: 0.138
-
Santin AD, Bellone S, Palmieri M, Bossini B, Dunn D, Roman JJ, Pecorelli S, Cannon M, Parham GP. Effect of blood transfusion during radiotherapy on the immune function of patients with cancer of the uterine cervix: role of interleukin-10. Int J Radiat Oncol Biol Phys. 2002 Dec 01; 54(5):1345-55.
Score: 0.136
-
Santin AD, Bellone S, Gokden M, Cannon MJ, Parham GP. Vaccination with HPV-18 E7-pulsed dendritic cells in a patient with metastatic cervical cancer. N Engl J Med. 2002 May 30; 346(22):1752-3.
Score: 0.131
-
Broutet N, Jeronimo J, Kumar S, Almonte M, Murillo R, Huy NVQ, Denny L, Kapambwe S, Bhatla N, Sebitloane M, Zhao F, Gravitt P, Adsul P, Rangaraj A, Dalal S, Newman M, Chowdhury R, Church K, Nakisige C, Diop M, Parham G, Thomson KA, Basu P, Steyn P. Implementation research to accelerate scale-up of national screen and treat strategies towards the elimination of cervical cancer. Prev Med. 2022 Feb; 155:106906.
Score: 0.127
-
Pinder LF, Parham GP, Basu P, Muwonge R, Lucas E, Nyambe N, Sauvaget C, Mwanahamuntu MH, Sankaranarayanan R, Prendiville W. Thermal ablation versus cryotherapy or loop excision to treat women positive for cervical precancer on visual inspection with acetic acid test: pilot phase of a randomised controlled trial. Lancet Oncol. 2020 01; 21(1):175-184.
Score: 0.110
-
Bing EG, Parham GP, Cuevas A, Fisher B, Skinner J, Mwanahamuntu M, Sullivan R. Using Low-Cost Virtual Reality Simulation to Build Surgical Capacity for Cervical Cancer Treatment. J Glob Oncol. 2019 05; 5:1-7.
Score: 0.106
-
Nyambe N, Hoover S, Pinder LF, Chibwesha CJ, Kapambwe S, Parham G, Subramanian S. Differences in Cervical Cancer Screening Knowledge and Practices by HIV Status and Geographic Location: Implication for Program Implementation in Zambia. Afr J Reprod Health. 2018 Dec; 22(4):92-101.
Score: 0.103
-
Mohammed SI, Ren W, Flowers L, Rajwa B, Chibwesha CJ, Parham GP, Irudayaraj JM. Point-of-care test for cervical cancer in LMICs. Oncotarget. 2016 Apr 05; 7(14):18787-97.
Score: 0.086
-
Manga S, Parham G, Benjamin N, Nulah K, Sheldon LK, Welty E, Ogembo JG, Bradford L, Sando Z, Shields R, Welty T. Cervical Cancer Screening in Cameroon: Interobserver Agreement on the Interpretation of Digital Cervicography Results. J Low Genit Tract Dis. 2015 Oct; 19(4):288-94.
Score: 0.083
-
Bateman AC, Katundu K, Mwanahamuntu MH, Kapambwe S, Sahasrabuddhe VV, Hicks ML, Chi BH, Stringer JS, Parham GP, Chibwesha CJ. The burden of cervical pre-cancer and cancer in HIV positive women in Zambia: a modeling study. BMC Cancer. 2015 Jul 24; 15:541.
Score: 0.082
-
Chamot E, Mulambia C, Kapambwe S, Shrestha S, Parham GP, Macwan'gi M, Mwanahamuntu MH. Preference for human papillomavirus-based cervical cancer screening: results of a choice-based conjoint study in Zambia. J Low Genit Tract Dis. 2015 Apr; 19(2):119-23.
Score: 0.080
-
Bateman AC, Katundu K, Polepole P, Shibemba A, Mwanahamuntu M, Dittmer DP, Parham GP, Chibwesha CJ. Identification of human papillomaviruses from formalin-fixed, paraffin-embedded pre-cancer and invasive cervical cancer specimens in Zambia: a cross-sectional study. Virol J. 2015 Jan 16; 12:2.
Score: 0.079
-
Bateman AC, Parham GP, Sahasrabuddhe VV, Mwanahamuntu MH, Kapambwe S, Katundu K, Nkole T, Mulundika J, Pfaendler KS, Hicks ML, Shibemba A, Vermund SH, Stringer JS, Chibwesha CJ. Clinical performance of digital cervicography and cytology for cervical cancer screening in HIV-infected women in Lusaka, Zambia. J Acquir Immune Defic Syndr. 2014 Oct 01; 67(2):212-5.
Score: 0.077
-
Denny LA, Sankaranarayanan R, De Vuyst H, Kim JJ, Adefuye PO, Alemany L, Adewole IF, Awolude OA, Parham G, de Sanjos? S, Bosch FX. Recommendations for cervical cancer prevention in sub-saharan Africa. Vaccine. 2013 Dec 29; 31 Suppl 5:F73-4.
Score: 0.073
-
Kapambwe S, Parham G, Mwanahamuntu M, Chirwa S, Mwanza J, Amuyunzu-Nyamongo M. Innovative approaches to promoting cervical health and raising cervical cancer awareness by use of existing cultural structures in resource-limited countries: experiences with traditional marriage counseling in Zambia. Glob Health Promot. 2013 Dec; 20(4 Suppl):57-64.
Score: 0.073
-
White HL, Mulambia C, Sinkala M, Mwanahamuntu MH, Parham GP, Moneyham L, Grimley DM, Chamot E. 'Worse than HIV' or 'not as serious as other diseases'? Conceptualization of cervical cancer among newly screened women in Zambia. Soc Sci Med. 2012 May; 74(10):1486-93.
Score: 0.065
-
White HL, Mulambia C, Sinkala M, Mwanahamuntu MH, Parham GP, Kapambwe S, Moneyham L, Kempf MC, Chamot E. Motivations and experiences of women who accessed "see and treat" cervical cancer prevention services in Zambia. J Psychosom Obstet Gynaecol. 2012 Jun; 33(2):91-8.
Score: 0.064
-
Sahasrabuddhe VV, Parham GP, Mwanahamuntu MH, Vermund SH. Cervical cancer prevention in low- and middle-income countries: feasible, affordable, essential. Cancer Prev Res (Phila). 2012 Jan; 5(1):11-7.
Score: 0.064
-
Waggoner SE, Darcy KM, Fuhrman B, Parham G, Lucci J, Monk BJ, Moore DH. Association between cigarette smoking and prognosis in locally advanced cervical carcinoma treated with chemoradiation: a Gynecologic Oncology Group study. Gynecol Oncol. 2006 Dec; 103(3):853-8.
Score: 0.044
-
Fouad MN, Partridge E, Dignan M, Holt C, Johnson R, Nagy C, Parham G, Person S, Scarinci I, Wynn T. A community-driven action plan to eliminate breast and cervical cancer disparity: successes and limitations. J Cancer Educ. 2006; 21(1 Suppl):S91-100.
Score: 0.042
-
Lanciano R, Calkins A, Bundy BN, Parham G, Lucci JA, Moore DH, Monk BJ, O'Connor DM. Randomized comparison of weekly cisplatin or protracted venous infusion of fluorouracil in combination with pelvic radiation in advanced cervix cancer: a gynecologic oncology group study. J Clin Oncol. 2005 Nov 20; 23(33):8289-95.
Score: 0.041
-
Parham GP, Hicks ML. Racial disparities affecting the reproductive health of African-American women. Med Clin North Am. 2005 Sep; 89(5):935-43, 941.
Score: 0.041
-
Cronj? HS, Parham GP, Cooreman BF, de Beer A, Divall P, Bam RH. A comparison of four screening methods for cervical neoplasia in a developing country. Am J Obstet Gynecol. 2003 Feb; 188(2):395-400.
Score: 0.034